News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
865,262 Results
Type
Article (87649)
Company Profile (824)
Press Release (776773)
Multimedia
Podcasts (182)
Webinars (28)
Section
Business (233149)
Career Advice (4142)
Deals (39826)
Drug Delivery (141)
Drug Development (91319)
Employer Resources (203)
FDA (18322)
Job Trends (17412)
News (397604)
Policy (39936)
Tag
Academia (3006)
Academic (2)
Accelerated approval (21)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (155)
Alzheimer's disease (1726)
Antibody-drug conjugate (ADC) (284)
Approvals (18392)
Artificial intelligence (554)
Autoimmune disease (122)
Automation (32)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (177)
Biotechnology (487)
Bladder cancer (143)
Brain cancer (57)
Breast cancer (550)
Cancer (4402)
Cardiovascular disease (392)
Career advice (3564)
Career pathing (39)
CAR-T (266)
CDC (57)
Cell therapy (735)
Cervical cancer (34)
Clinical research (76158)
Collaboration (1520)
Company closure (4)
Compensation (1009)
Complete response letters (64)
COVID-19 (2968)
CRISPR (92)
C-suite (681)
Cystic fibrosis (144)
Data (5357)
Decentralized trials (2)
Denatured (66)
Depression (125)
Diabetes (483)
Diagnostics (7136)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (259)
Drug pricing (201)
Drug shortages (36)
Duchenne muscular dystrophy (215)
Earnings (99838)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (134063)
Executive appointments (1004)
FDA (21036)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (21)
Funding (1375)
Gene editing (197)
Generative AI (54)
Gene therapy (597)
GLP-1 (1066)
Government (5405)
Grass and pollen (8)
Guidances (377)
Healthcare (20941)
HIV (54)
Huntington's disease (43)
IgA nephropathy (76)
Immunology and inflammation (268)
Immuno-oncology (27)
Indications (66)
Infectious disease (3232)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (108)
Intellectual property (207)
Interviews (816)
IPO (17937)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (87)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (626)
Lymphoma (308)
Machine learning (35)
Management (66)
Manufacturing (709)
MASH (163)
Medical device (14945)
Medtech (14983)
Mergers & acquisitions (22839)
Metabolic disorders (1254)
Multiple sclerosis (147)
NASH (23)
Neurodegenerative disease (277)
Neuropsychiatric disorders (78)
Neuroscience (2869)
NextGen: Class of 2025 (7703)
Non-profit (5098)
Now hiring (60)
Obesity (597)
Opinion (321)
Ovarian cancer (149)
Pain (176)
Pancreatic cancer (189)
Parkinson's disease (259)
Partnered (32)
Patents (446)
Patient recruitment (363)
Peanut (58)
People (66499)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23492)
Phase II (33047)
Phase III (24922)
Pipeline (3493)
Policy (314)
Postmarket research (3554)
Preclinical (10622)
Press Release (72)
Prostate cancer (219)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (736)
Real estate (7431)
Recruiting (80)
Regulatory (28328)
Reports (65)
Research institute (2709)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (16)
RSV (81)
Schizophrenia (144)
Series A (223)
Series B (168)
Service/supplier (30)
Sickle cell disease (87)
Special edition (26)
Spinal muscular atrophy (173)
Sponsored (42)
Startups (4322)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (96)
The Weekly (114)
Vaccines (1079)
Venture capital (74)
Weight loss (420)
Women's health (70)
Worklife (21)
Date
Today (117)
Last 7 days (639)
Last 30 days (3792)
Last 365 days (33395)
2025 (30798)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (318)
Arkansas (14)
Asia (51172)
Australia (9000)
California (10464)
Canada (3063)
China (991)
Colorado (441)
Connecticut (472)
Delaware (301)
Europe (117718)
Florida (1528)
Georgia (340)
Hawaii (3)
Idaho (68)
Illinois (859)
India (59)
Indiana (506)
Iowa (21)
Japan (351)
Kansas (130)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1372)
Massachusetts (7768)
Michigan (331)
Minnesota (608)
Mississippi (6)
Missouri (131)
Montana (34)
Nebraska (27)
Nevada (112)
New Hampshire (81)
New Jersey (2865)
New Mexico (32)
New York (2803)
North Carolina (1499)
North Dakota (10)
Northern California (4884)
Ohio (319)
Oklahoma (22)
Oregon (51)
Pennsylvania (2141)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (57)
South Dakota (1)
Southern California (4015)
Tennessee (161)
Texas (1634)
United States (38156)
Utah (315)
Vermont (1)
Virginia (265)
Washington D.C. (85)
Washington State (877)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
There are 865,262 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Novartis Expands Spinal Muscular Atrophy Gene Therapy Market With FDA’s Itvisma Greenlight
The FDA approved an intrathecal form of Novartis’ spinal muscular atrophy gene therapy Zolgensma on Monday, broadening access to patients two years and older in what one Stanford Medicine professor called a “game changing advance” for the field.
November 25, 2025
·
2 min read
·
Heather McKenzie
Mergers & acquisitions
Avidity Played Hardball to Land Favorable Terms in $12B Novartis Deal
At one point in merger negotiations with Novartis, Avidity CEO Sarah Boyce and her team walked, cutting off access to a data room and moving on to a capital raise.
November 25, 2025
·
3 min read
·
Annalee Armstrong
Layoff Tracker
Novartis Cuts 550 Employees as Swiss Manufacturing Priorities Shift
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
November 25, 2025
·
92 min read
·
BioSpace Editorial Staff
Obesity
Novo Bounces Back With ‘Competitive’ Mid-Stage Weight Loss Data for Amycretin
Novo Nordisk’s amycretin showed no weight-loss plateau over 36 weeks in patients with type 2 diabetes, suggesting its efficacy could become even stronger with longer follow-up, according to analysts at BMO Capital Markets.
November 25, 2025
·
2 min read
·
Tristan Manalac
Weight loss
Lilly Redefines the Pharma Mega-Blockbuster
Previous mega blockbusters took years to reach their peak sales. Lilly’s tirzepatide franchise is on course to exceed them just a few years in.
November 25, 2025
·
2 min read
·
Annalee Armstrong
Cancer
Late-Stage Data For J&J’s Tecvayli/Darzalex Combo Could ‘Shift Paradigm’ in Myeloma
Tecvayli plus Darzalex led to an 83% boost to progression-free survival versus the current standard therapy in relapsed or refractory multiple myeloma, results analysts at Guggenheim Securities called “remarkable.”
November 25, 2025
·
2 min read
·
Tristan Manalac
FDA
Pazdur Questions Safety, Legality of FDA’s Expedited Drug Approval Programs
Richard Pazdur, the new director of the Center for Drug Evaluation and Research, raised concerns amid the rollout of several FDA initiatives seeking to shorten the drug review process.
November 25, 2025
·
2 min read
·
Tristan Manalac
Government
Former DARPA Official Jackson Named ARPA-H Head
Alicia Jackson formerly served as deputy director of the Biological Technologies Office at the Defense Advanced Research Projects Agency.
November 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
·
1 min read
Press Releases
Catalyx Report Reveals Persistent Manufacturing Bottlenecks in Life Sciences Industry
November 25, 2025
·
4 min read
1 of 86,527
Next
